http://www.medcitynews.com/2009/06/louisiana-pharma-startup-theravasc-moves-readies-for-clinical-trials/?utm_source=rss&utm_medium=rss&utm_campaign=louisiana-pharma-startup-theravasc-moves-readies-for-clinical-trials MedCity News Sat, 11 Feb 2012 15:17:29 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.medcitynews.com/2009/06/louisiana-pharma-startup-theravasc-moves-readies-for-clinical-trials/comment-page-1/#comment-49315 Theravasc Inc. wins $500,000 investment commitment to try vascular disease drug : MedCity News Wed, 06 Jan 2010 05:10:29 +0000 http://www.medcitynews.com/?p=7107#comment-49315 [...] June, Theravasc received a $100,000 grant from the Innovation Fund at the Lorain County Community College [...] [...] June, Theravasc received a $100,000 grant from the Innovation Fund at the Lorain County Community College [...]

]]> http://www.medcitynews.com/2009/06/louisiana-pharma-startup-theravasc-moves-readies-for-clinical-trials/comment-page-1/#comment-18217 Angel-esque Medical Growth Fund to focus on Cleveland area : MedCity News Mon, 31 Aug 2009 18:55:17 +0000 http://www.medcitynews.com/?p=7107#comment-18217 [...] already started to favor medical-industry enterprises. For example, a $100,000 GLIDE grant in June lured the Louisiana drug startup Theravasc into the [...] [...] already started to favor medical-industry enterprises. For example, a $100,000 GLIDE grant in June lured the Louisiana drug startup Theravasc into the [...]

]]> http://www.medcitynews.com/2009/06/louisiana-pharma-startup-theravasc-moves-readies-for-clinical-trials/comment-page-1/#comment-7181 No emergencies — just emergency physicians, MedCity Weekend Rounds June 19, 2009 : MedCity News Sat, 20 Jun 2009 04:05:37 +0000 http://www.medcitynews.com/?p=7107#comment-7181 [...] recruited a pharmaceutical startup from Louisiana, while the promising imaging company Imalux hired a new CEO to take a new version of its product to [...] [...] recruited a pharmaceutical startup from Louisiana, while the promising imaging company Imalux hired a new CEO to take a new version of its product to [...]

]]>